Company Filing History:
Years Active: 2000-2013
Title: Tejal B Vyas: Innovator in Biopharmaceuticals
Introduction
Tejal B Vyas is a prominent inventor based in Mississauga, Canada. She has made significant contributions to the field of biopharmaceuticals, holding a total of seven patents. Her work primarily focuses on glucagon-like peptide-2 receptors, which have important implications in drug development and screening.
Latest Patents
Among her latest patents, Tejal has developed inventions related to cloned glucagon-like peptide-2 receptors. These inventions encompass nucleotides and amino acid sequences that encode glucagon-like peptide-2 receptors. Additionally, her patents include recombinant host cells transformed with these nucleotides, along with methods for utilizing them in drug screening and related applications.
Career Highlights
Tejal has worked with notable companies in the biopharmaceutical sector, including Allelix Biopharmaceuticals Inc. and NPS Pharmaceuticals, Inc. Her experience in these organizations has allowed her to advance her research and contribute to innovative solutions in the industry.
Collaborations
Throughout her career, Tejal has collaborated with esteemed colleagues such as Donald G Munroe and Ashwani K Gupta. These partnerships have further enriched her work and expanded the impact of her inventions.
Conclusion
Tejal B Vyas is a trailblazer in the field of biopharmaceuticals, with a strong portfolio of patents that reflect her innovative spirit and dedication to advancing medical science. Her contributions continue to influence drug development and therapeutic applications.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.